Phase IV Solutions & RWE, Labcorp Drug Development

Labcorp Drug Development has more than 30 years of experience designing and executing Phase IV, pharmacovigilance, and real-world evidence (RWE) studies globally. We have deep expertise in epidemiology, study design, health economics and outcomes research, real-world data (RWD), safety, and patient-reported outcomes across all therapeutic areas in drugs and devices. We offer a full portfolio of services to provide innovative solutions for interventional studies, non-interventional studies, pragmatic trials, disease and drug registries, and database studies to examine efficacy/effectiveness and Other clinical outcomes, quality of life and Other patient-reported outcomes, safety, drug utilization, and healthcare resource use.